Partnering for development of JAK 3 kinase programme anticipated to be concluded in the first quarter of 2006 which is getting pretty close - and the good thing is it will be tax free- doesnt get better than that!
CYT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held